ClinicalTrials.Veeva

Menu

MRI Scan and Intra-labyrinthine Schwannoma

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Schwannoma

Treatments

Other: No intervention in this restrospective study

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Evaluate the interest of gadolinium for the positive and topographic diagnosis of intra-labyrinthine schwannoma, comparing T1 sequence acquired after gadolinium injection to a sequence of fast imaging type employing steady state acquisition (FIESTA-C)

Enrollment

30 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-80 years
  • Have intra-labyrinthine schwannoma
  • Have benefited from an MRI with gadolinium injection on the MRI 3T with interpretable sequences of good quality
  • Subject giving their consent for their participation
  • Subjects who benefited, between 2009 and 2016, from an MRI of the external auditory canals, with gadolinous product injection and on the 3 Tesla MRI, in which a diagnosis of intra labyrinthine schwannoma was made

Exclusion criteria

  • Refusal to participate in the study

Trial contacts and locations

1

Loading...

Central trial contact

Francis VEILLON, MD, PhD; Aïna VENKATASAMY, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems